- Home
- /
- News
- /
- Regulatory
- /
- June 2010
Regulatory News for June 2010
The UK launch of Sativex®, GW Pharmaceuticals’ oromucosal spray for the treatment of spasticity caused by multiple sclerosis, has been announced.
21 June, 2010
Latest NICE cost–benefit guidance includes Sandoz’s Omnitrope® as one of seven recommended somatropin products to treat growth failure in children.
11 June, 2010
Stakeholders celebrate ten years of success of the EU regulation on orphan medicines at the European Parliament.
04 June, 2010
Amgen announced recently that Prolia (denosumab), a new type of osteoporosis treatment for post-menopausal women, has been granted marketing authorization in the UK.
03 June, 2010